Sanofi SNY
NASDAQ SNY
$41.47 -0.49 (-1.17%)
As of: Oct 23, 2026 · 2:15 PM EDT

Sanofi (SNY) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Sanofi (SNY) recorded Return on Capital Employed [ROCE] of 3.31% in the quarter ended Jun 30, 2026, down 4.68 percentage points from 7.99% a year earlier.

Analysis

Sanofi (SNY) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2023, Sanofi reported Return on Capital Employed [ROCE] of 6.91%.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +1.37 percentage points (years ended Dec 2018 to Dec 2023).
  • Across earlier years, Return on Capital Employed [ROCE] came in at 8.64% in the year ended Dec 31, 2021 (-27.79 pp), 36.44% in the year ended Dec 31, 2020 (+30.96 pp) and 5.48% in the year ended Dec 31, 2019 (-0.06 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn 17.52%
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn 16.76%
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -5.97%
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 11.86%
10 Sanofi 50.62 Bn 17.14 Bn 10.79 Bn 6.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.10%
Dec 31, 2025 6.07%
Jun 30, 2025 7.75%
Dec 31, 2018 12.40%
Sep 30, 2018 10.11%
Jun 30, 2018 4.36%
Mar 31, 2018 5.87%
API Access

Sanofi Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SNY&period=max&api_key=YOUR_API_KEY